Cargando…

Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial

OBJECTIVES: Okara is a major food by-product of soymilk or tofu production, particularly rich in dietary fiber. Biovalorization with Rhizopus oligosporus can improve its nutritional quality with greater soluble fiber, bioavailable isoflavones, and antioxidants. These nutrients are fermented by the g...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Delia Pei Shan, Gan, Alicia Xinli, Xia, Xuejuan, Toh, Kate Qi Xuan, Chan, Gregory, Jung, Sangyong, Kim, Jung Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193693/
http://dx.doi.org/10.1093/cdn/nzac069.022
_version_ 1784726527417516032
author Lee, Delia Pei Shan
Gan, Alicia Xinli
Xia, Xuejuan
Toh, Kate Qi Xuan
Chan, Gregory
Jung, Sangyong
Kim, Jung Eun
author_facet Lee, Delia Pei Shan
Gan, Alicia Xinli
Xia, Xuejuan
Toh, Kate Qi Xuan
Chan, Gregory
Jung, Sangyong
Kim, Jung Eun
author_sort Lee, Delia Pei Shan
collection PubMed
description OBJECTIVES: Okara is a major food by-product of soymilk or tofu production, particularly rich in dietary fiber. Biovalorization with Rhizopus oligosporus can improve its nutritional quality with greater soluble fiber, bioavailable isoflavones, and antioxidants. These nutrients are fermented by the gut microbiota to generate gut metabolites involved in gut health maintenance. This study evaluates the impact of okara and biovalorized okara- containing biscuits consumption on gut health in middle-aged and older Singaporeans. METHODS: Healthy participants (n = 15) of the crossover trial were randomly allocated to 3-week interventions of 100 g of control (C), 20% flour substituted autoclaved okara- (AOK), and 20% four substituted R. oligosporus biovalorized okara- (RO) containing biscuits, with 3-week washout periods. Pre- and post- intervention serum short-chain fatty acids (SCFA), fecal SCFA, fecal bile acids, serum zonulin, gastrointestinal symptoms, and dietary intakes were assessed. Pre- and post- intervention fecal 16S ribosomal RNA V3-V4 sequencing was also investigated for gut microbiome analysis. Results are presented as change value mean (95% confidence interval). RESULTS: Amongst fecal SCFA, only valeric acid (µmol/g) observed a significant difference, higher with RO compared to AOK (0.16 (0.01, 0.30) vs −0.20 (−0.34, −0.05), P = 0.005). RO and AOK had significantly higher total serum SCFA (P = 0.002 & 0.018 respectively) and serum acetic acid (P = 0.007 & 0.030 respectively) compared to C. RO had significant improvements with higher serum propionic acid (µmol/L) (RO: 3.04 (0.80, 5.27) vs C: −2.65 (−4.97, −0.33), P = 0.004) and lower fecal lithocholic acid (mg/g) (a secondary bile acid) (RO: −0.11 (−0.20, −0.02) vs C: 0.10 (0.01, 0.19), P = 0.009) contrasted to C. Although serum zonulin showed no significant difference, AOK induced a reduction in Clostridiales while RO increased Bifidobacterium. Okara consumption increased dietary fiber intake, with greater soluble fiber intake from RO compared to AOK and C (P = 0.018 & 0.019 respectively), aligning with the greater flatulence felt by participants on RO. CONCLUSIONS: Okara consumption improved serum SCFA rather than fecal SCFA, regardless of fermentation. Biovalorized okara consumption further improved SCFA and bile acid profiles by modulating gut microbiome. FUNDING SOURCES: Singapore Ministry of Education.
format Online
Article
Text
id pubmed-9193693
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91936932022-06-14 Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial Lee, Delia Pei Shan Gan, Alicia Xinli Xia, Xuejuan Toh, Kate Qi Xuan Chan, Gregory Jung, Sangyong Kim, Jung Eun Curr Dev Nutr Nutritional Microbiology/Microbiome OBJECTIVES: Okara is a major food by-product of soymilk or tofu production, particularly rich in dietary fiber. Biovalorization with Rhizopus oligosporus can improve its nutritional quality with greater soluble fiber, bioavailable isoflavones, and antioxidants. These nutrients are fermented by the gut microbiota to generate gut metabolites involved in gut health maintenance. This study evaluates the impact of okara and biovalorized okara- containing biscuits consumption on gut health in middle-aged and older Singaporeans. METHODS: Healthy participants (n = 15) of the crossover trial were randomly allocated to 3-week interventions of 100 g of control (C), 20% flour substituted autoclaved okara- (AOK), and 20% four substituted R. oligosporus biovalorized okara- (RO) containing biscuits, with 3-week washout periods. Pre- and post- intervention serum short-chain fatty acids (SCFA), fecal SCFA, fecal bile acids, serum zonulin, gastrointestinal symptoms, and dietary intakes were assessed. Pre- and post- intervention fecal 16S ribosomal RNA V3-V4 sequencing was also investigated for gut microbiome analysis. Results are presented as change value mean (95% confidence interval). RESULTS: Amongst fecal SCFA, only valeric acid (µmol/g) observed a significant difference, higher with RO compared to AOK (0.16 (0.01, 0.30) vs −0.20 (−0.34, −0.05), P = 0.005). RO and AOK had significantly higher total serum SCFA (P = 0.002 & 0.018 respectively) and serum acetic acid (P = 0.007 & 0.030 respectively) compared to C. RO had significant improvements with higher serum propionic acid (µmol/L) (RO: 3.04 (0.80, 5.27) vs C: −2.65 (−4.97, −0.33), P = 0.004) and lower fecal lithocholic acid (mg/g) (a secondary bile acid) (RO: −0.11 (−0.20, −0.02) vs C: 0.10 (0.01, 0.19), P = 0.009) contrasted to C. Although serum zonulin showed no significant difference, AOK induced a reduction in Clostridiales while RO increased Bifidobacterium. Okara consumption increased dietary fiber intake, with greater soluble fiber intake from RO compared to AOK and C (P = 0.018 & 0.019 respectively), aligning with the greater flatulence felt by participants on RO. CONCLUSIONS: Okara consumption improved serum SCFA rather than fecal SCFA, regardless of fermentation. Biovalorized okara consumption further improved SCFA and bile acid profiles by modulating gut microbiome. FUNDING SOURCES: Singapore Ministry of Education. Oxford University Press 2022-06-14 /pmc/articles/PMC9193693/ http://dx.doi.org/10.1093/cdn/nzac069.022 Text en © The Author 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Nutritional Microbiology/Microbiome
Lee, Delia Pei Shan
Gan, Alicia Xinli
Xia, Xuejuan
Toh, Kate Qi Xuan
Chan, Gregory
Jung, Sangyong
Kim, Jung Eun
Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial
title Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial
title_full Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial
title_fullStr Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial
title_full_unstemmed Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial
title_short Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial
title_sort biovalorized okara consumption improves gut metabolites by modulating gut microbiome: a randomized controlled crossover trial
topic Nutritional Microbiology/Microbiome
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193693/
http://dx.doi.org/10.1093/cdn/nzac069.022
work_keys_str_mv AT leedeliapeishan biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial
AT ganaliciaxinli biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial
AT xiaxuejuan biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial
AT tohkateqixuan biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial
AT changregory biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial
AT jungsangyong biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial
AT kimjungeun biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial